The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
about
Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applicationsVaccines against drugs of abuse: where are we now?Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month periodSimple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkages.Impact of distinct chemical structures for the development of a methamphetamine vaccineSelection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceSynthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody ResponseAnti-(+)-methamphetamine monoclonal antibody antagonists designed to prevent the progression of human diseases of addictionMonoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addictionOptimization of a methamphetamine conjugate vaccine for antibody production in miceChronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use.Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities.Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained ratsStructure-immunogenicity relationship of kresoxim-methyl regioisomeric haptens.Forchlorfenuron-mimicking haptens: from immunogen design to antibody characterization by hierarchical clustering analysis.
P2860
Q26864041-5E0E7740-FC23-461E-820C-1559A9F31998Q33776777-965CC9E3-D59B-458D-BD08-4D7FC2C22222Q34602548-0DB90C51-B859-453D-A6CF-5062AD83F6FEQ34764446-3F65F49C-7E7C-46C0-A787-5EE3DC6A2CECQ34956542-851DC58F-7DCC-410C-891F-9D9E31C471B4Q35009554-3E56EC3E-8969-4BB7-845E-FCE9D59B3660Q35120379-784447A8-9B76-4102-8278-6BB64C8B25D4Q35151502-E253084E-784D-4A1E-99EC-0FD64274C273Q35498227-E8C6E241-A83A-4025-845D-757233BF6F05Q36148294-8601088D-14A3-4BD4-BF58-6D0B71B9E3A2Q36838980-89688E09-CF5A-436E-9F0F-CE9E79B240D6Q36842878-19358C16-6428-43F3-B965-A31AF0445617Q36854009-33BBFFA7-8DDC-4341-B91D-1C80EF5D419EQ37264923-57D42B38-0F92-40D5-8C21-741A3B5B4A94Q37329852-A5423217-2E8D-47C4-BAAA-39CA1CAF0B97Q37698954-F68695FE-C91D-44E6-A96C-DE440D0DE6EDQ40431126-9942E412-0FB1-43F5-8965-7BA50E99010EQ41843198-27BF932D-A5F7-41FF-8C7F-9439A7BC5847Q43925020-6233B1E7-20E5-4F60-8C3A-B3BA81654E9AQ46053356-350A0E9C-1D07-460F-8966-D8A00954AF92
P2860
The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The synthesis of haptens and t ...... reating methamphetamine abuse.
@ast
The synthesis of haptens and t ...... reating methamphetamine abuse.
@en
The synthesis of haptens and t ...... reating methamphetamine abuse.
@nl
type
label
The synthesis of haptens and t ...... reating methamphetamine abuse.
@ast
The synthesis of haptens and t ...... reating methamphetamine abuse.
@en
The synthesis of haptens and t ...... reating methamphetamine abuse.
@nl
prefLabel
The synthesis of haptens and t ...... reating methamphetamine abuse.
@ast
The synthesis of haptens and t ...... reating methamphetamine abuse.
@en
The synthesis of haptens and t ...... reating methamphetamine abuse.
@nl
P2093
P2860
P356
P1476
The synthesis of haptens and t ...... reating methamphetamine abuse.
@en
P2093
Amber Hampton
Bruce E Blough
Eric C Peterson
F Ivy Carroll
Melinda Gunnell
Paul K Gong
Philip Abraham
Ramakrishna R Pidaparthi
S Michael Owens
Yingni Che
P2860
P304
P356
10.1021/JM901134W
P407
P577
2009-11-01T00:00:00Z